| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating activities: | ||||||||
Net loss | ||||||||
-85,632 | -86,300 | -88,005 | -83,450 | -71,159 | -61,700 | 0 | 0 | 0 |
Reconciliation of net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
1,376 | 1,300 | 1,235 | 1,089 | 937 | 800 | 0 | 0 | 0 |
Equity-based compensation | ||||||||
10,265 | 10,068 | 10,242 | 11,155 | 9,258 | 6,964 | 0 | 0 | 0 |
Amortization of debt discount | ||||||||
0 | - | - | - | - | - | - | - | - |
Non-cash interest expense | ||||||||
161 | 0 | 54 | 54 | 53 | 62 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||||
- | - | - | - | 0 | - | - | - | - |
Fair Value Adjustment of Warrants | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Changes in: | ||||||||
Prepaid expenses and other assets | ||||||||
1,022 | 1,881 | 1,150 | 1,544 | 2,197 | -40 | 0 | 0 | 0 |
Accounts payable | ||||||||
-1,347 | -684 | -127 | 313 | 931 | 1,837 | 0 | 0 | 0 |
Accrued expense and other liabilities | ||||||||
4,523 | 1,349 | 3,296 | 2,877 | 2,165 | 4,721 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||
-70,903 | -75,800 | -74,286 | -69,131 | -59,638 | -46,300 | 0 | 0 | 0 |
Investing activities: | ||||||||
Purchase of property and equipment | ||||||||
3,535 | 3,586 | 3,647 | 3,941 | 3,850 | 3,002 | 0 | 0 | 0 |
Net cash and restricted cash used in investing activities | ||||||||
-3,535 | -3,586 | -3,647 | -3,941 | -3,850 | -3,002 | 0 | 0 | 0 |
Financing activities: | ||||||||
Proceeds from preferred stock financing, net of issuance costs | ||||||||
- | - | - | - | - | 100,732 | 0 | 0 | 0 |
Proceeds from exercise of stock options | ||||||||
2,131 | 630 | 568 | 246 | 178 | 120 | 0 | 0 | 0 |
Payments related to capital lease | ||||||||
88 | 91 | 96 | 101 | 104 | 105 | 0 | 0 | 0 |
Issuance of common stock, net of issuance costs | ||||||||
- | 67,761 | 67,761 | 68,422 | 69,443 | 0 | 0 | 0 | 0 |
Settlement of derivative liability | ||||||||
- | 300 | 300 | 300 | 300 | 0 | 0 | 0 | 0 |
Net cash provided by financing activities | ||||||||
7,003 | 74,642 | 66,577 | 66,446 | 97,184 | 98,907 | 0 | 0 | 0 |
Net (decrease) increase in cash, cash equivalents, and restricted cash | ||||||||
-67,431 | -4,740 | -11,372 | -6,642 | 33,680 | 49,589 | 0 | 0 | 0 |
Supplemental cash flow information | ||||||||
Interest paid | ||||||||
978 | 881 | 982 | 967 | 960 | 943 | 0 | 0 | 0 |
Supplemental disclosure of non-cash investing and financing activities | ||||||||
Vesting of restricted shares | ||||||||
395 | 717 | 1,245 | 2,008 | 2,262 | 2,095 | 0 | 0 | 0 |
Reclassification of warrants to additional paid-in capital | ||||||||
- | 871 | 871 | 871 | 871 | 0 | 0 | 0 | 0 |
Conversion of preferred stock to common stock upon closing of the initial public offering | ||||||||
- | 153,226 | 153,226 | 153,226 | 153,226 | 0 | 0 | 0 | 0 |
Deferred Offering Costs Incurred But Not Yet Paid | ||||||||
- | - | - | - | - | - | - | - | 0 |
Purchase of property and equipment in accounts payable and accrued expenses | ||||||||
- | 385 | 649 | 1,082 | 418 | 604 | 0 | 0 | 0 |
Initial public offering costs incurred but unpaid at period end | ||||||||
- | - | 0 | 0 | 0 | - | - | - | - |